 AGOURA HILLS, California, Jan. 25, 2021 GLOBE NEWSWIRE -- Mateon Therapeutics, Inc. OTCQB:MATN Mateon, a leading developer of TGF-β therapeutics for oncology and infectious diseases, announced that it will be launching its mobile app, ARTIHealthTM, for respiratory health assessment, in India along with its COVID-19 therapeutic, PulmoHealTM also known as ARTIVedaTM, for total care of COVID-19 patients. 